With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
UAE President welcomes King of Jordan upon arrival on fraternal visit
H.H. Sheikh Hamdan selects first recipient of Mohammed bin Rashid leadership medal
Gargash says meeting with Iranian President reflects UAE's 'deterrence and diplomacy'
UAE condemns drone attack on Saudi oil pipeline
